Colchicine shows promise as a treatment for at-home COVID-19 patients -- Recruitment of participants in the COLCORONA phase 3 study likely to end in 2020

MONTREAL, Nov. 28, 2020 /PRNewswire/ -- The Montreal Heart Institute (MHI) today announced that the COLCORONA clinical trial will continue to recruit non-hospitalized adult patients with COVID-19 as recommended by the independent data monitoring committee (DMC), following a second interim...

from PR Newswire: https://ift.tt/3mk5uo7